Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 4
2018 2
2020 2
2021 12
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Antigen discovery by bioinformatics analysis and peptide microarray for the diagnosis of cystic echinococcosis.
Batisti Biffignandi G, Vola A, Sassera D, Najafi-Fard S, Gomez Morales MA, Brunetti E, Teggi A, Goletti D, Petrone L, Tamarozzi F. Batisti Biffignandi G, et al. Among authors: najafi fard s. PLoS Negl Trop Dis. 2023 Apr 12;17(4):e0011210. doi: 10.1371/journal.pntd.0011210. eCollection 2023 Apr. PLoS Negl Trop Dis. 2023. PMID: 37043489 Free PMC article.
Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy.
Najafi-Fard S, Petruccioli E, Farroni C, Petrone L, Vanini V, Cuzzi G, Salmi A, Altera AMG, Navarra A, Alonzi T, Nicastri E, Palmieri F, Gualano G, Carlini V, Noonan DM, Albini A, Goletti D. Najafi-Fard S, et al. Front Immunol. 2022 Sep 6;13:984098. doi: 10.3389/fimmu.2022.984098. eCollection 2022. Front Immunol. 2022. PMID: 36148228 Free PMC article.
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine.
Agrati C, Castilletti C, Goletti D, Sacchi A, Bordoni V, Mariotti D, Notari S, Matusali G, Meschi S, Petrone L, Aiello A, Najafi Fard S, Farroni C, Colavita F, Lapa D, Leone S, Agresta A, Capobianchi M, Ippolito G, Vaia F, Puro V; INMI COVID-19 Vaccine Study Group. Agrati C, et al. Among authors: najafi fard s. Sci Rep. 2022 Apr 23;12(1):6687. doi: 10.1038/s41598-022-07741-z. Sci Rep. 2022. PMID: 35461335 Free PMC article.
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Alonzi T, Aiello A, Petrone L, Najafi Fard S, D'Eletto M, Falasca L, Nardacci R, Rossin F, Delogu G, Castilletti C, Capobianchi MR, Ippolito G, Piacentini M, Goletti D. Alonzi T, et al. Among authors: najafi fard s. Cells. 2021 Dec 24;11(1):52. doi: 10.3390/cells11010052. Cells. 2021. PMID: 35011614 Free PMC article.
Multi-omics approach to COVID-19: a domain-based literature review.
Montaldo C, Messina F, Abbate I, Antonioli M, Bordoni V, Aiello A, Ciccosanti F, Colavita F, Farroni C, Najafi Fard S, Giombini E, Goletti D, Matusali G, Rozera G, Rueca M, Sacchi A, Piacentini M, Agrati C, Fimia GM, Capobianchi MR, Lauria FN, Ippolito G. Montaldo C, et al. Among authors: najafi fard s. J Transl Med. 2021 Dec 7;19(1):501. doi: 10.1186/s12967-021-03168-8. J Transl Med. 2021. PMID: 34876157 Free PMC article. Review.
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.
Tortorella C, Aiello A, Gasperini C, Agrati C, Castilletti C, Ruggieri S, Meschi S, Matusali G, Colavita F, Farroni C, Cuzzi G, Cimini E, Tartaglia E, Vanini V, Prosperini L, Haggiag S, Galgani S, Quartuccio ME, Salmi A, Repele F, Altera AMG, Cristofanelli F, D'Abramo A, Bevilacqua N, Corpolongo A, Puro V, Vaia F, Capobianchi MR, Ippolito G, Nicastri E, Goletti D; INMI COVID-19 Vaccine Study Group. Tortorella C, et al. Neurology. 2022 Feb 1;98(5):e541-e554. doi: 10.1212/WNL.0000000000013108. Epub 2021 Nov 22. Neurology. 2022. PMID: 34810244 Free PMC article.
ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients.
Picchianti-Diamanti A, Aiello A, Laganà B, Agrati C, Castilletti C, Meschi S, Farroni C, Lapa D, Najafi Fard S, Cuzzi G, Cimini E, Grassi G, Vanini V, Di Rosa R, Salemi S, Nalli G, Salmi A, Repele F, Altera AMG, Maffongelli G, Palazzolo C, Vita S, Leone S, Puro V, Capobianchi MR, Ippolito G, Nicastri E, Goletti D. Picchianti-Diamanti A, et al. Among authors: najafi fard s. Front Immunol. 2021 Sep 14;12:740249. doi: 10.3389/fimmu.2021.740249. eCollection 2021. Front Immunol. 2021. PMID: 34594343 Free PMC article.
25 results